Bellevue Asset Management (Switzerland)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LTI
BIT
Bellevue Asset Management (Switzerland)'s BMY Position: Q4 2015 in Review
Bellevue Asset Management (Switzerland) held its Bristol-Myers Squibb (BMY) position steady in Q4 2015 at 60,000 shares worth $4.13M. The position accounts for 0.63% of the portfolio, ranked #55.
Bellevue Asset Management (Switzerland) first reported a position in BMY in Q1 2015 and has held it in 4 quarters since. 1,535 funds tracked by Wall St. Rank hold BMY as of Q4 2015.
- Bellevue Asset Management (Switzerland) held 60,000 shares of Bristol-Myers Squibb worth $4.13M as of Q4 2015.
- Bellevue Asset Management (Switzerland) left its Bristol-Myers Squibb share count unchanged in Q4 2015.
- Bristol-Myers Squibb made up 0.63% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #55 holding.
- Bellevue Asset Management (Switzerland) first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 4 quarters since.
- 1,535 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.
Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.